今日观察！A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.

库迪咖啡澄清门店关闭传闻：累计闭店率仅2.6% 致力长期发展

[上海，2024年6月14日] 近日，有关库迪咖啡大量门店关闭的传闻在网络上流传。对此，库迪咖啡方面今日正式回应，称该传闻不实，公司累计闭店率仅为2.6%，彰显了库迪咖啡强劲的发展势头和良好的经营状况。

针对网传的“大量门店关闭”信息，库迪咖啡首席策略官李颖波表示，该数据系基于不合理测算方式得出，存在严重偏差。

“有关部门统计的门店关闭数据，通常以门店开业一年及以上为样本进行统计。而库迪咖啡大部分门店开业时间不到一年，特别是2023年下半年新开门店数量较多，如果以此为基准计算闭店率，显然失之偏颇。”李颖波解释道。

据库迪咖啡提供的数据显示，截至2024年5月，库迪咖啡累计闭店率仅为2.6%，远低于行业平均水平。 同时，公司五月份现金流为正的门店占比高达96%，充分反映了加盟商的盈利能力和门店的健康经营状况。

李颖波强调，库迪咖啡始终坚持“轻资产、重运营”的发展模式，并建立了一套完善的加盟体系和运营管理机制，助力加盟商实现盈利。

“公司会持续关注市场动态，不断优化经营策略，为加盟商提供更优质的服务和支持，携手共创咖啡新蓝海。”李颖波最后说道。

近年来，中国咖啡市场快速发展，竞争日趋激烈。 在此背景下，库迪咖啡凭借独特的商业模式和强劲的发展势头，迅速崛起成为中国咖啡市场不可忽视的力量。

此次澄清门店关闭传闻，充分展现了库迪咖啡的诚信经营和负责任态度。 相信在公司管理层的带领下，库迪咖啡将继续深耕中国咖啡市场，为广大消费者带来更加优质的咖啡体验，并取得更大的成功。

附赠：

• 库迪咖啡官网：https://kudicoffee.com/

通过此次新闻稿的撰写，我对库迪咖啡的发展现状和未来前景有了更深入的了解。我相信，库迪咖啡将继续为中国咖啡市场的繁荣发展贡献力量。